224 related articles for article (PubMed ID: 34535841)
1. Classification of NF1 microdeletions and its importance for establishing genotype/phenotype correlations in patients with NF1 microdeletions.
Kehrer-Sawatzki H; Cooper DN
Hum Genet; 2021 Dec; 140(12):1635-1649. PubMed ID: 34535841
[TBL] [Abstract][Full Text] [Related]
2. Emerging genotype-phenotype relationships in patients with large NF1 deletions.
Kehrer-Sawatzki H; Mautner VF; Cooper DN
Hum Genet; 2017 Apr; 136(4):349-376. PubMed ID: 28213670
[TBL] [Abstract][Full Text] [Related]
3. Genotype-Phenotype Associations in Patients With Type-1, Type-2, and Atypical
Büki G; Zsigmond A; Czakó M; Szalai R; Antal G; Farkas V; Fekete G; Nagy D; Széll M; Tihanyi M; Melegh B; Hadzsiev K; Bene J
Front Genet; 2021; 12():673025. PubMed ID: 34168676
[TBL] [Abstract][Full Text] [Related]
4. Atypical
Kehrer-Sawatzki H; Wahlländer U; Cooper DN; Mautner VF
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681033
[TBL] [Abstract][Full Text] [Related]
5. High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene.
Kehrer-Sawatzki H; Kluwe L; Sandig C; Kohn M; Wimmer K; Krammer U; Peyrl A; Jenne DE; Hansmann I; Mautner VF
Am J Hum Genet; 2004 Sep; 75(3):410-23. PubMed ID: 15257518
[TBL] [Abstract][Full Text] [Related]
6. Identification of an
Büki G; Bekő A; Bödör C; Urbán P; Németh K; Hadzsiev K; Fekete G; Kehrer-Sawatzki H; Bene J
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686382
[TBL] [Abstract][Full Text] [Related]
7. Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions.
Mußotter T; Kluwe L; Högel J; Nguyen R; Cooper DN; Mautner VF; Kehrer-Sawatzki H
BMC Med Genet; 2012 Oct; 13():98. PubMed ID: 23101500
[TBL] [Abstract][Full Text] [Related]
8. NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype.
Pasmant E; Sabbagh A; Spurlock G; Laurendeau I; Grillo E; Hamel MJ; Martin L; Barbarot S; Leheup B; Rodriguez D; Lacombe D; Dollfus H; Pasquier L; Isidor B; Ferkal S; Soulier J; Sanson M; Dieux-Coeslier A; Bièche I; Parfait B; Vidaud M; Wolkenstein P; Upadhyaya M; Vidaud D;
Hum Mutat; 2010 Jun; 31(6):E1506-18. PubMed ID: 20513137
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the clinical phenotype associated with mosaic type-2 NF1 microdeletions.
Kehrer-Sawatzki H; Vogt J; Mußotter T; Kluwe L; Cooper DN; Mautner VF
Neurogenetics; 2012 Aug; 13(3):229-36. PubMed ID: 22581253
[TBL] [Abstract][Full Text] [Related]
10. The NF1 microdeletion syndrome: early genetic diagnosis facilitates the management of a clinically defined disease.
Kehrer-Sawatzki H; Bäzner U; Krämer J; Lewerenz J; Pfeiffer C
J Dtsch Dermatol Ges; 2022 Mar; 20(3):273-277. PubMed ID: 35246941
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromatosis type 1: Expanded variant spectrum with multiplex ligation-dependent probe amplification and genotype-phenotype correlation in 138 Turkish patients.
Güneş N; Yeşil G; Geyik F; Kasap B; Celkan T; Kebudi R; Tüysüz B
Ann Hum Genet; 2021 Sep; 85(5):155-165. PubMed ID: 33877690
[TBL] [Abstract][Full Text] [Related]
12. Clinical characterization of children and adolescents with NF1 microdeletions.
Kehrer-Sawatzki H; Kluwe L; Salamon J; Well L; Farschtschi S; Rosenbaum T; Mautner VF
Childs Nerv Syst; 2020 Oct; 36(10):2297-2310. PubMed ID: 32533297
[TBL] [Abstract][Full Text] [Related]
13. Exonic deletions in the NF1 gene in patients with neurofibromatosis type I from the lower Silesian region of Poland.
Laczmańska I; Szczepaniak M; Jakubiak A; Stembalska A
Adv Clin Exp Med; 2014; 23(4):517-21. PubMed ID: 25166435
[TBL] [Abstract][Full Text] [Related]
14. Absence of cutaneous neurofibromas in an NF1 patient with an atypical deletion partially overlapping the common 1.4 Mb microdeleted region.
Kehrer-Sawatzki H; Schmid E; Fünsterer C; Kluwe L; Mautner VF
Am J Med Genet A; 2008 Mar; 146A(6):691-9. PubMed ID: 18265407
[TBL] [Abstract][Full Text] [Related]
15. NF1 microdeletion syndrome: case report of two new patients.
Serra G; Antona V; Corsello G; Zara F; Piro E; Falsaperla R
Ital J Pediatr; 2019 Nov; 45(1):138. PubMed ID: 31703719
[TBL] [Abstract][Full Text] [Related]
16. Delineation of the clinical phenotype associated with non-mosaic type-2 NF1 deletions: two case reports.
Vogt J; Nguyen R; Kluwe L; Schuhmann M; Roehl AC; Mußotter T; Cooper DN; Mautner VF; Kehrer-Sawatzki H
J Med Case Rep; 2011 Dec; 5():577. PubMed ID: 22151963
[TBL] [Abstract][Full Text] [Related]
17. Droplet Digital PCR for Fast and Accurate Characterization of NF1 Locus Deletions: Confirmation of the Predominant Maternal Origin of Type-1 Deletions.
Pacot L; Ye M; Nectoux J; Laurendeau I; Briand-Suleau A; Coustier A; Maillard T; Barbance C; Orhant L; Vaucouleur N; Blanché H; Parfait B; Wolkenstein P; Vidaud M; ; Vidaud D; Pasmant E
J Mol Diagn; 2024 Feb; 26(2):150-157. PubMed ID: 38008284
[TBL] [Abstract][Full Text] [Related]
18. Growth in neurofibromatosis 1 microdeletion patients.
Ning X; Farschtschi S; Jones A; Kehrer-Sawatzki H; Mautner VF; Friedman JM
Clin Genet; 2016 Mar; 89(3):351-4. PubMed ID: 26111455
[TBL] [Abstract][Full Text] [Related]
19. [Neurofibromatosis-1 microdeletion syndrome.].
Büki G; Till Á; Zsigmond A; Bene J; Hadzsiev K
Orv Hetil; 2022 Dec; 163(51):2041-2051. PubMed ID: 36528827
[TBL] [Abstract][Full Text] [Related]
20. Ultra-deep amplicon sequencing indicates absence of low-grade mosaicism with normal cells in patients with type-1 NF1 deletions.
Summerer A; Schäfer E; Mautner VF; Messiaen L; Cooper DN; Kehrer-Sawatzki H
Hum Genet; 2019 Jan; 138(1):73-81. PubMed ID: 30478644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
